caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1699752857

John CraddockM.D.

OtolaryngologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where John Craddock's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
51173
Randall Brauchle
Otolaryngology · Houston, TX
40124
Christopher Prichard
Otolaryngology · Houston, TX
38166
Daniel Franklin
Otolaryngology · Houston, TX
37109
EDWARDS, TASHA3548
NPI 14876315602771
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER2698
CHI ST. LUKE'S HEALTH BAYLOR COLLEGE OF MEDICINE MEDICAL CENTER2353
Saween Thompson
Diagnostic Radiology · Houston, TX
1426
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
1320
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,322
Unique beneficiaries
—
Total services
4,899
Distinct HCPCS
15
Medicare payment
$103K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 668 Otolaryngology providers in TX — top quintile (cohort median 967).
PRESCRIBING · PART D · 2024
Total Rx claims
460
Beneficiaries
—
Total drug cost
$20K
Distinct drugs
16
Brand share
15.2%
Top prescribed drugs
Ipratropium Bromide56 claims
Doxycycline Hyclate53 claims
Ofloxacin41 claims
Omeprazole39 claims
Methylprednisolone37 claims
QUALITY · MIPS · 2024
Final MIPS score
95.8
Quality
11.6
Cost
71.4
Improvement activities
40.0
Promoting interop.
95.0
Payment adjustment
0.87%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$130
Payment records
5
By payment type
Food and Beverage$130